\
&
Contact us
\
&
Contact us
Published on | 2 years ago
Programmes EIC EIC PilotThe evaluation study assesses the performance of the European Innovation Council (EIC) Pilot (2018-2020) against its objective of supporting breakthrough innovation and the scaling up of European deep-tech start-ups. The study looks at how the programme was delivered and at the early results that have been achieved to identify valuable lessons for improving the European Innovation Council (EIC) in Horizon Europe (2021-2027). (from the executive summary of the study)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
